MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today provided a business update around the Company’s recently-filed 2015 Transitional Report for the eight-month period ending December 31, 2015.
